Drugs / BAY987516
last change Jan 2017 re-read 3 minutes ago

BAY987516

Investigated by
Bayer

Trials 8

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02995122 Dec 2016 → Jan 2017 — Bayer Completed No outcome recorded
— NCT02994992 Dec 2016 → Jan 2017 — Bayer Completed No outcome recorded
— NCT02930798 Oct 2016 — Bayer Completed No outcome recorded
— NCT02930746 Oct 2016 — Bayer Completed No outcome recorded
— NCT02930772 Oct → Nov 2016 — Bayer Completed No outcome recorded
— NCT02930759 Oct 2016 — Bayer Completed No outcome recorded
— NCT02885805 Jun → Jul 2015 — Bayer Completed No outcome recorded
— NCT02872246 May → Jul 2015 — Bayer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as BAY987516 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02930798 ↗
7

NCT02930746 ↗

NCT02885805 ↗

NCT02995122 ↗

NCT02930759 ↗

NCT02994992 ↗

NCT02872246 ↗

NCT02930772 ↗

Route Topical “on the skin of human subjects” NCT02872246 ↗